<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/047EBC73-8511-4B50-9680-1D19A68EA3E8"><gtr:id>047EBC73-8511-4B50-9680-1D19A68EA3E8</gtr:id><gtr:name>Free University of Amsterdam</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/047EBC73-8511-4B50-9680-1D19A68EA3E8"><gtr:id>047EBC73-8511-4B50-9680-1D19A68EA3E8</gtr:id><gtr:name>Free University of Amsterdam</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7BDAF2A5-BCA2-45E4-86FB-397D23791323"><gtr:id>7BDAF2A5-BCA2-45E4-86FB-397D23791323</gtr:id><gtr:firstName>Nick</gtr:firstName><gtr:surname>Gilbert</gtr:surname><gtr:orcidId>0000-0003-0505-6081</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UU_12018%2F24"><gtr:id>F881B3C7-237C-4B8D-9CEC-A416230B5201</gtr:id><gtr:title>Investigating chromatin and DNA structure to understand transcriptional regulation and genome stability</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UU_12018/24</gtr:grantReference><gtr:abstractText>In every mammalian cell DNA is packaged into chromatin, a massive nucleoprotein complex. As fundamental nuclear processes such as gene transcription, replication and repair occur in this environment it is important for us to understand chromatin and genome architecture. In this programme will investigate the packaging of DNA in the human genome and investigate how this influences gene expression programmes, DNA replication and chromosome stability. In many human diseases including cancer the genome becomes fragile and certain regions of the genome have a propensity to becoming unstable. We will investigate the DNA topology and chromatin organisation of these fragile regions and identify the factors that make them unstable. Our research will enable us to characterise the mechanistic basis for many chromosomal aberrations and identify approaches that can be use to reduce the likelihood of genome instability. One of the first steps in cancer is the acquisition of genome instability. Characterising this process will better enable us to comprehend the factors and mechanism involved and may in future enable us to either better detect early changes in cancer or develop new approaches for reducing the likelihood of cancer growth.</gtr:abstractText><gtr:technicalSummary>This aim of this programme is to investigate chromatin structure and DNA topology to understand the fundamental mechanisms important for regulating gene transcription and genome stability. In mammalian cells all nuclear processes such as transcription, DNA replication and repair occur on a chromatin template so it is critical to understand its structure. Despite many years of research the structure of chromatin is highly contentious. We are using high-resolution microscopy techniques to understand chromatin fibre structure. This information will give insight into the fundamental building blocks that are critical for protecting the genome. To further investigate chromatin/DNA structure and function we are developing novel molecules in collaboration with the chemistry department that can be used as structure probes. These studies will enable us understand the relationship between chromatin structure and the regulation of transcription and genome stability. As an experimental model we are using cell lines and tissues from healthy individuals and patients with human genetic diseases. This experimental approach will enable us to better understand how the cell works normally and how it goes wrong during disease. To study genome stability we are using common-fragile sites as a model. These are regions of the genome that are present in all individuals but have a propensity to break under replication stress. By using a defined experimental system, like fragile sites, will enable us to better understand how the genome maintains its structural integrity and protects the DNA from damage.

A number of human genetic diseases are directly linked to mutations in chromatin proteins and in diseases like cancer many genes are aberrantly expressed, caused by a loss of genome integrity. Understanding how DNA is packaged in human cells will give new insights into the mechanism of human disease and will lead to the development of new biomarkers and treatments

The new molecules being developed in this project have two main purposes (i) as tools to investigate chromatin/DNA structure and (ii) as reagents that can be used to treat patients with diseases such are cancer. As these reagents have IP-potential we are investigating future commercial possibilities. Developmental of these reagents will promote interactions with industry and biotech companies leading to future better treatments.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-08-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>193620</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Chromatin fibre simulations and modelling</gtr:description><gtr:id>76281F1C-5689-4FEB-92A1-C855582E2581</gtr:id><gtr:impact>None yet but have applied for a grant. First publications are currently in revision</gtr:impact><gtr:outcomeId>54306d74624dd7.55307040-1</gtr:outcomeId><gtr:partnerContribution>Developed mathematical models</gtr:partnerContribution><gtr:piContribution>Developed research questions and experimental data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Free University of Amsterdam</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Genome-wide chromatin analysis</gtr:description><gtr:id>E40A31A1-01F7-4791-91D8-90FEA47B9B26</gtr:id><gtr:impact>Publication
PMID: 23416946</gtr:impact><gtr:outcomeId>BtqtTGbkTr4-1</gtr:outcomeId><gtr:partnerContribution>Provided expertise in examining genome-wide data</gtr:partnerContribution><gtr:piContribution>Utilise collaborators expertise to investigate genome-wide chromatin data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Novel tools for investigating chromatin structure</gtr:description><gtr:id>C6B0E136-3F66-405F-BBD8-B03EDA851BD7</gtr:id><gtr:impact>Publications
PMID: 23416946
PMID: 23417870</gtr:impact><gtr:outcomeId>oQgTJoe12C9-1</gtr:outcomeId><gtr:partnerContribution>Provided expertise for synthesising new drug compounds</gtr:partnerContribution><gtr:piContribution>Developed new ideas for developing new molecular biology tools</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Lab twitter feed</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B2DA90BF-9A96-4CEF-B21E-F886B1ACAFE2</gtr:id><gtr:impact>Active lab twitter feed. 100 unique engagements per month and 7000 hits per month. Commenting on current science topics, our research and science-related news-worthy activities.
@chromatinlab</gtr:impact><gtr:outcomeId>56e0567dd5a807.85889677</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>389083</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Multi-User Equipment Grant</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>104915/Z/14/Z</gtr:fundingRef><gtr:id>5DDBCEF7-674E-425B-942F-0E984F282426</gtr:id><gtr:outcomeId>56dda1182fb539.74938846</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have developed a new drug for treating certain types of cancer</gtr:description><gtr:id>EEC16D00-7506-44DB-AB8B-99C89612B26C</gtr:id><gtr:impact>We are currently in discussion with companies for its further development</gtr:impact><gtr:outcomeId>54306a453f9903.17541955</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>New anti cancer drug</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed a new photoactivatable DNA-DNA cross linker for molecular biology research</gtr:description><gtr:id>7351F585-DC80-444E-9CBB-546B3A9B335E</gtr:id><gtr:impact>We are currently optimising techniques before applying for further funding</gtr:impact><gtr:outcomeId>54306a9c133cf1.74324255</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>New DNA-DNA crosslinker</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D121795B-603B-497E-83A5-66BA75D3175A</gtr:id><gtr:title>cGAS surveillance of micronuclei links genome instability to innate immunity.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdb7873ab95bbdbd121d17277f61d31e"><gtr:id>cdb7873ab95bbdbd121d17277f61d31e</gtr:id><gtr:otherNames>Mackenzie KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5a292eabe6f777.52378750</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59D85788-9A01-4F7C-A478-AC136B31BE82</gtr:id><gtr:title>Polymers for the cell-specific immobilisation of megakaryocytic cell lines.</gtr:title><gtr:parentPublicationTitle>Macromolecular bioscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81686f057dd6effc6daccf7d2b693322"><gtr:id>81686f057dd6effc6daccf7d2b693322</gtr:id><gtr:otherNames>Hansen A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1616-5187</gtr:issn><gtr:outcomeId>pm_24676_26_23417870</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C6A63DB-DD62-4DD8-8074-EBDACB745F7D</gtr:id><gtr:title>Stochastic Model of Supercoiling-Dependent Transcription.</gtr:title><gtr:parentPublicationTitle>Physical review letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d87292c502efcf92b713683b2fa01cbc"><gtr:id>d87292c502efcf92b713683b2fa01cbc</gtr:id><gtr:otherNames>Brackley CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0031-9007</gtr:issn><gtr:outcomeId>58c79952839962.83721134</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>118C2B7D-A592-4287-AF7C-ABD93E02E7BC</gtr:id><gtr:title>Effects of DNA supercoiling on chromatin architecture.</gtr:title><gtr:parentPublicationTitle>Biophysical reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56dd77cd6148b7d0af284505a9b90ea3"><gtr:id>56dd77cd6148b7d0af284505a9b90ea3</gtr:id><gtr:otherNames>Corless S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1867-2450</gtr:issn><gtr:outcomeId>58c79abb087a99.75609558</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UU_12018/24</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>